South Korea Biopharmaceutical Excipients Market Size & Outlook
South Korea biopharmaceutical excipients market, 2018-2030 (US$M)
Related Markets
South Korea biopharmaceutical excipients market highlights
- The South Korea biopharmaceutical excipients market generated a revenue of USD 47.3 million in 2023 and is expected to reach USD 74.6 million by 2030.
- The South Korea market is expected to grow at a CAGR of 6.7% from 2024 to 2030.
- In terms of segment, carbohydrates was the largest revenue generating product in 2023.
- Polyols is the most lucrative product segment registering the fastest growth during the forecast period.
Biopharmaceutical excipients market data book summary
| Market revenue in 2023 | USD 47.3 million |
| Market revenue in 2030 | USD 74.6 million |
| Growth rate | 6.7% (CAGR from 2023 to 2030) |
| Largest segment | Carbohydrates |
| Fastest growing segment | Polyols |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Specialty Excipients/Others, Solubilizes & Surfactants/Emulsifiers, Polyols, Carbohydrates |
| Key market players worldwide | Merck KGaA, Basf SE, Associated British Foods PLC, IMCD NV, Clariant AG, Evonik Industries AG, Colorcon, Sigachi, Spectrum Chemical Manufacturingrp, Roquette America, DFE Pharma, J. Rettenmaier & Söhne |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.8% of the global biopharmaceutical excipients market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China biopharmaceutical excipients market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 355.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopharmaceutical Excipients Market Scope
Biopharmaceutical Excipients Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Korea biopharmaceutical excipients market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical excipients market will help companies and investors design strategic landscapes.
Carbohydrates was the largest segment with a revenue share of 35.94% in 2023. Horizon Databook has segmented the South Korea biopharmaceutical excipients market based on specialty excipients/others, solubilizes & surfactants/emulsifiers, polyols, carbohydrates covering the revenue growth of each sub-segment from 2018 to 2030.
In addition, local pharma players such as Dong-A Pharmaceuticals are expanding their operation in biopharma by signing partnership with international companies like Bayer and Meiji.
Key global market players supply their products through subsidiaries or local distributors in South Korea. Daeyeon Chemicals Co. LTD is a distributor of Spectrum Chemical Manufacturing Corp in the country. Identifying the potential opportunities owing to rapid progress of biopharma industry, many international companies are expanding their operations in this market.
Reasons to subscribe to South Korea biopharmaceutical excipients market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea biopharmaceutical excipients market databook
-
Our clientele includes a mix of biopharmaceutical excipients market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea biopharmaceutical excipients market , including forecasts for subscribers. This country databook contains high-level insights into South Korea biopharmaceutical excipients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea biopharmaceutical excipients market size, by product, 2018-2030 (US$M)
South Korea Biopharmaceutical Excipients Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
